|
Laura Fernández-Fernández, Lola Bellido-Martín*, Pablo García de Frutos
Department of Cell Death and Proliferation, Institute for Biomedical Research of Barcelona, IIBB-CSIC-IDIBAPS, Barcelona, Spain; *Present address: Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
GAS6 (growth arrest-specific 6) belongs structurally to the family of plasma vitamin K-dependent proteins. GAS6 has a high structural homology with the natural anticoagulant protein S, sharing the same modular composition and having 40% sequence identity. Despite this, the low concentration of GAS6 in plasma and the pattern of tissue expression of GAS6 suggest a distinct function among vitamin-K dependent proteins. Indeed, GAS6 has growth factor-like properties through its interaction with receptor tyrosine kinases of the TAM family;Tyro3,Axl and MerTK. GAS6 employs a unique mechanism of action, interacting through its vitamin K-dependent GLA (γ-carboxyglutamic acid) module with phosphatidylserine-containing membranes and through its carboxy-terminal LamG domains with the TAM membrane receptors. During the last years there has been a considerable expansion of our knowledge of the biology ofTAM receptors that has lead to a clear picture of their importance in inflammation, haemostasis and cancer, making this system an interesting target in biomedicine. The innate immune response and the coagulation cascade have been shown to be interconnected. Mediators of inflammation are essential in the initiation and propagation of the coagulation cascade, while natural anticoagulants have important anti-inflammatory functions. GAS6 represents a new player in this context,while protein S seems to have new functions beyond its anticoagulant role through its interaction with TAM receptors.
inflammation, growth factors, vitamin K, innate immunity, receptor tyrosine kinases, GLA
| 1. | ||
Inga-Maria Frick, Lars Björck, Heiko Herwald Thrombosis and Haemostasis 2007 98 3: 497-502 http://dx.doi.org/10.1160/TH07-01-0051 | ||
| 2. | ||
Horst von Bernuth 1, 2, Stephan Ehl 3 Kinder- und Jugendmedizin 2008 8 2: 93-100 | ||
| 3. | ||
Helene Hochart1, P. Vincent Jenkins1,2, Roger J. S. Preston1, Owen P. Smith3, Barry White1,2, James O’Donnell1,2 Thrombosis and Haemostasis 2008 99 3: 570-575 http://dx.doi.org/10.1160/TH07-06-0424 | ||